Press Releases

Khurshid Guru, MD, one of the most experienced and accomplished robotic surgeons in the world, has been named Chair of the Department of Urology at Roswell Park Cancer Institute. James Mohler, MD, has assumed the new role of Chief of Inter-Institutional Academics and will act as Roswell Park’s point person and liaison for translational research collaborations between Roswell Park and the University at Buffalo.

A new study from Roswell Park Cancer Institute reporting the findings of the first clinical trial to evaluate the immune effects of high-dose radiation therapy followed by surgery in patients with advanced kidney cancer may also set the stage for combination treatments with immunotherapy.

Ryan Grady, CPA, has been appointed Vice President of Finance and Payer Relations at Roswell Park Cancer Institute and will lead the Institute’s finance team. He will oversee Roswell Park’s financial reporting, accounting and treasury management operations, financial planning and reimbursement operations.

An international team of researchers has performed a follow-up analysis based on a large clinical study of a maintenance therapy for patients with multiple myeloma. Philip McCarthy, MD, of Roswell Park Cancer Institute was principal investigator of a phase III study that showed that treatment with lenalidomide following autologous hematopoietic stem cell transplant improved both progression-free survival and overall survival for newly diagnosed multiple myeloma patients.